Skip to main content
JAKAFI 20 mg/1 tablet by Incyte Corporation
JAKAFI, 20 mg/1, tablet Drug class: Janus Kinase Inhibitor; Kinase Inhibitor. Available on prescription only. Listed by Incyte Corporation.
Prescription only

JAKAFI

ruxolitinib

Listed by Incyte Corporation

Strength
20 mg/1
Form
Tablet
Route
Oral
Class
Janus Kinase Inhibitor; Kinase Inhibitor

What it contains

  • Ruxolitinib 20 mg/1

FDA record

Dosage form Tablet
Route Oral
Drug class Janus Kinase Inhibitor; Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 50881-020
FDA application NDA202192
RxNorm concept 1193331
Package sizes listed 1
Marketed since November 2011

Other products containing Ruxolitinib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

JAKAFI

ruxolitinib

Strength
10 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
25 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
15 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
5 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
33 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
11 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
55 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
44 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.